Skip to
  1. Homepage
  2. Diagnostic tests
  3. Search
Simple search

Simple search

*
(*) mandatory field




 

Other search option(s)

62 matching term(s)

Result(s)sorted by

Caption : Accreditation =Accreditation
;

    • SWITZERLAND
    • Suisse Romande
    • GENÈVE
    • Accreditation
    • Molecular diagnosis of familial paraparesis (deletion/duplication by MLPA for SPG4 and SPG3A genes)
    • Centre Médical Universitaire - CMU
    • More information
    • GERMANY
    • Nordrhein-Westfalen
    • BOCHUM
    • Accreditation
    • Molecular diagnosis of familial spastic paraplegia SPG3, SPG4, SPG7, SPG10, SPG11, SPG13 and SPG31 (ATL1, HSP60, KIF5A, REEP1, SPAST, SPG7, SPG11 genes)
    • Ruhr-Universität Bochum
    • More information
    • GERMANY
    • Bayern
    • NEU-ULM
    • Accreditation
    • Molecular diagnosis of familial spastic paraplegia type 4 (SPAST gene)
    • Paxis und Labor Dr. med Karl Mehnert
    • More information
    • PORTUGAL
    • NORTE
    • PORTO
    • Accreditation
    • Molecular diagnosis of Familial dominant spastic paraplegia, SPG3A, SPG4, SPG42, SPG10, SPG31, SPG8, SPG17, SPG6, SPG13 (ALT1, SPAST, SLC33A1, KIF5A, REEP1, KIAA0196, BSCL2, NIPA1 and HSPD1 genes)
    • Instituto de Biologia Molecular e Celular
    • More information
    • BELGIUM
    • VLAAMS BRABANT
    • LEUVEN
    • Accreditation
    • Molecular diagnosis of Autosomal dominant spastic paraplegia type 4 (SPG4 gene)
    • University Hospitals Leuven - Gasthuisberg
    • More information
    • UNITED KINGDOM
    • South Yorkshire
    • SHEFFIELD
    • Accreditation
    • Molecular diagnosis of Familial Spastic Paraplegia type 4 - SPG4 (Spastin gene)
    • Sheffield Children's NHS Foundation Trust
    • More information
    • GERMANY
    • Hamburg
    • HAMBURG
    • Accreditation
    • Molecular diagnosis of familial spastic paraplegia (ATL1 and SPAST genes: sequencing / MLPA)
    • GenteQ GmbH
    • More information
    • BELGIUM
    • HAINAUT
    • GOSSELIES
    • Accreditation
    • Molecular diagnosis of familial spastic paraplegia (SPG3, SPG4, BSCL2, PLP1 genes)
    • Institut de Pathologie et de Génétique - Gosselies
    • More information
    • GERMANY
    • Bayern
    • REGENSBURG
    • Accreditation
    • Molecular diagnosis of spastic paraplegia (ATL1, B4GALNT1, CYP7B1, REEP1, SPAST, SPG7, SPG11, SPG14, SPG20, SPG21, ZFYVE26 genes: sequencing, NGS panel spastic paraplegia, MLPA, linkage analysis)
    • Universitätsklinikum Regensburg
    • More information
    • NETHERLANDS
    • Gelderland
    • NIJMEGEN
    • Accreditation
    • Molecular diagnosis of Autosomal Dominant Spastic Paraplegia type 3A, 4, 6, 8, 10, 12, 13, 17, 31 and 42 (ATL1, SPAST, NIPA1, KIAA0196, KIF5A, RTN2, HSPD1, BSCL2, REEP1 and SLC33A1 gene)
    • Radboudumc - Radboud universitair medisch centrum
    • More information
    • GERMANY
    • Baden-Württemberg
    • FREIBURG
    • Accreditation
    • Molecular diagnosis of spastic paraplegia type 3, 4, 6- 8, 10, 11, 12, 15, 17, 20, 21, 31, 35, 39, 42, 44 (ATL1, BSCL2, FA2H, GJC2, KIAA0196, KIF5A, NIPA1, PNPLA6, REEP1, RTN2, SLC33A1, SPAST, SPG7, SPG11, SPG20, SPG21, ZFYVE26 genes)
    • Praxis für Humangenetik Freiburg
    • More information
    • GERMANY
    • Thüringen
    • JENA
    • Accreditation
    • Molecular diagnosis of familial spastic paraplegia SPG3A, SPG4 and SPG31 (ATL1, REEP1, SPAST genes)
    • Universitätsklinikum Jena
    • More information
    • GERMANY
    • Mecklenburg-Vorpommern
    • ROSTOCK
    • Accreditation
    • Molecular diagnosis of spastic paraplegia (genes: ATL1, ACP33, BSCL2, CYP7B1, C12ORF65, FA2H, HSPD1, KIAA0196, KIF5A, L1CAM, NIPA1, PLP1, PNPLA6, REEP1, SLC33A1, SPAST, SPG3A, SPG7, SPG11, SPG20, SPG21, ZFYVE26 and ZFYVE27)
    • Centogene AG
    • More information
    • GERMANY
    • Baden-Württemberg
    • KARLSRUHE
    • Accreditation
    • Molecular diagnosis of familial spastic paraplegia (ATL1, PLP1, SPAST genes)
    • Labor PD Dr. Volkmann und Kollegen
    • More information
    • GERMANY
    • Hamburg
    • HAMBURG
    • Accreditation
    • Molecular diagnosis of spastic paraplegia (ACP33, BSCL2, CYP7B1, HSPD1, KIAA0196, KIF5A, L1CAM, NIPA1, REEP1, SLC33A1, SPAST, SPG3a, SPG7, SPG11, SPG20, PLP1, ZFYVE26 genes)
    • MVZ Fenner & Krasemann
    • More information
    • UNITED KINGDOM
    • Greater London
    • LONDON
    • Accreditation
    • Molecular diagnosis of Familial Spastic Paraplegia (Spastin, Atlastin, NIPA1 & REEP1 genes)
    • Guy's Hospital
    • More information
    • UNITED KINGDOM
    • Greater London
    • LONDON
    • Accreditation
    • Molecular diagnosis of Spastic Paraplegia 4, Autosomal Dominant (SPAST gene: Sequencing of the entire coding region of gene (s) plus copy number analysis by MLPA)
    • Guy's Hospital
    • More information
    • GERMANY
    • Baden-Württemberg
    • TÜBINGEN
    • Accreditation
    • Molecular diagnosis of spastic paraplegia type 2, 4, 7, 10, 15, 20, 31, 55 (C12ORF65, GJC2, KIF5A, PLP1, REEP1, SPG7, SPAST, SPG20, ZFYVE26 genes: sequencing)
    • CeGaT GmbH
    • More information
    • CANADA
    • Ontario
    • TORONTO
    • Accreditation
    • Molecular diagnosis of AR Hereditary Spastic Paraplegia (by DNA sequencing)
    • University of Toronto
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Molecular diagnosis of autosomal dominant spastic paraplegia type 4 (SPAST gene)
    • CHU Paris - Hôpital Necker-Enfants Malades
    • More information
    • FRANCE
    • NORD-PAS-DE-CALAIS
    • LILLE
    • Molecular diagnostic of type 4 autosomal dominant spastic paraplegia (SPAST gene)
    • CHRU de Lille - Centre de biologie pathologie génétique
    • More information
    • FRANCE
    • ALSACE
    • SCHILTIGHEIM
    • Preimplantation genetic diagnosis of autosomal dominant spastic paraplegia type 4 (SPAST gene)
    • Centre Médico-Chirurgical et Obstétrical (CMCO)
    • More information
    • ITALY
    • TOSCANA
    • PISA
    • Molecular diagnosis of spastic paraplegia (SPAST, SPG3A, REEP1 and SPG7 genes)
    • Azienda Ospedaliero Universitaria Pisana - Ospedale S. Chiara
    • More information
    • ITALY
    • VENETO
    • COSTOZZA DI LONGARE
    • Molecular diagnosis of familial spastic paraplegia, type 4 (SPAST gene)
    • B.I.R.D. Foundation
    • More information
    • SPAIN
    • Asturias
    • OVIEDO
    • Molecular diagnosis of autosomal dominant spastic paraplegia, types 3, 4, 6 and 31 (ATL1 gene / sequence of exons 2-13; NIPA1 and REEP1 genes / mutations; SPAST gene / sequence of exons 1-17)
    • Hospital Universitario Central de Asturias
    • More information
    • GERMANY
    • Niedersachsen
    • GÖTTINGEN
    • Molecular diagnosis of familial spastic paraplegia (ATL1, SPAST, SPG7, SPG11 and REEP1 genes)
    • Universitätsmedizin Göttingen
    • More information
    • SPAIN
    • Galicia
    • SANTIAGO DE COMPOSTELA
    • Molecular diagnosis of autosomal dominant spastic paraplegia type 4 (SPAST gene)
    • CHUS - Complejo Hospitalario Universitario de Santiago
    • More information
    • ITALY
    • LOMBARDIA
    • MILANO
    • Molecular diagnosis of spastic paraplegia (SPAST, SPG7 genes)
    • IRCCS Ospedale San Raffaele
    • More information
    • SPAIN
    • Cataluña
    • L'HOSPITALET DE LLOBREGAT
    • Molecular diagnosis of autosomal dominant spastic paraplegia type 4. SPAST gene
    • IDIBELL - Instituto de Investigación Biomédica de Bellvitge
    • More information
    • GERMANY
    • Baden-Württemberg
    • TÜBINGEN
    • Molecular diagnosis of familial spastic paraplegia (ATL1, SPAST, SPG11, SPG21 and SPG7 genes)
    • Universitätsklinikum Tübingen
    • More information
    • FRANCE
    • RHONE-ALPES
    • BRON
    • Molecular diagnosis of autosomal dominant spastic paraplegia type 4 (SPAST gene)
    • CHU de Lyon-GH Est - Hospices Civils de Lyon
    • More information
    • FINLAND
    • Finland
    • TURKU
    • Molecular diagnosis of spastic paraplegia 4 (SPAST gene)
    • University of Turku
    • More information
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Molecular diagnosis of autosomal dominant spastic paraplegia type 4 (SPAST gene)
    • CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
    • More information
    • SPAIN
    • Comunidad Valenciana
    • PATERNA
    • Molecular diagnosis of autosomal dominant spastic paraplegia type 4 (SPAST gene)
    • Sistemas Genómicos S.L.
    • More information
    • AUSTRIA
    • STEIERMARK
    • GRAZ
    • Molecular diagnosis of autosomal dominant spastic paraplegia type 4 (SPG4 gene)
    • Medizinische Universität Graz
    • More information
    • GERMANY
    • Niedersachsen
    • OSNABRÜCK
    • Molecular diagnosis of familial spastic paraplegia (ATL1, PLP1, SPAST, SPG7, SPG11 and REEP1 genes)
    • Praxis Dres. Gencik
    • More information
    • AUSTRIA
    • WIEN
    • WIEN
    • Molecular diagnosis of spastic paraplegia (SPG2, 3, 4, and 7, and REEP1 genes)
    • Medizinische Universität Wien
    • More information
    • AUSTRIA
    • WIEN
    • WIEN
    • Molecular diagnosis of Spastic Paraplegia (PLP1, ATL1, SPAST, SPG7, SPG11, and SPG20 genes)
    • Praxis für Humangenetik
    • More information
    • BELGIUM
    • ANTWERPEN
    • ANTWERPEN
    • Molecular diagnosis of Familial spastic paraplegia (ATL1 and SPAST genes, SPAST gene dosage)
    • University of Antwerp - UA
    • More information
    • PORTUGAL
    • NORTE
    • PORTO
    • Molecular diagnosis of spastic paraplegia 1, 3A, 4, 5A, 10, 11, 15, 17, 20, 21, 28, 30, 31, 39, 42, 48, (L1CAM, KIF5A, SPG11, SPG15, BSCL2, SPG20, SPG21, KIF1A, REEP1, PNPLA6, DDHD1, ATL1, SPAST, SLC33A1, KIAA0415, CYP7B1 genes: Sequencing of the entire coding region for all genes and deletion/duplication by MLPA for ATL1 and SPAST genes)
    • CGC Genetics / Centro de Genética Clínica
    • More information
    • SPAIN
    • Comunidad Valenciana
    • SANT JOAN D'ALACANT
    • Molecular diagnosis of autosomal dominant spastic paraplegia type 4 (SPAST gene / entire coding sequence, MLPA)
    • Centro Inmunológico de Alicante (CIALAB)
    • More information
    • NORWAY
    • Østlandet
    • OSLO
    • Molecular diagnosis of familial spastic paraplegia (SPG4 gene)
    • Oslo University Hospital, Ullevaal
    • More information
    • GERMANY
    • Mecklenburg-Vorpommern
    • ROSTOCK
    • Molecular diagnosis of spastic paraplegia (genes: ACP33, BSCL2, CYP7B1, HSPD1, KIAA0196, KIF5A, L1CAM, NIPA1, REEP1, SPAST, SPG3a, SPG7, SPG11(KIAA1840), SPG20, PLP1, ZFYVE26)
    • Diagenom GmbH
    • More information
    • SPAIN
    • Andalucía
    • MÁLAGA
    • Molecular diagnosis of autosomal dominant spastic paraplegia, type 4 (SPAST gene: MLPA)
    • Genetaq
    • More information
    • SPAIN
    • Comunidad Valenciana
    • PATERNA
    • Molecular diagnosis of autosomal dominant spastic paraplegia type 4. SPAST gene (complete sequencing).
    • IMEGEN - Instituto de Medicina Genómica
    • More information
    • SPAIN
    • Comunidad Valenciana
    • PATERNA
    • Molecular diagnosis of autosomal dominant spastic paraplegia type 4 (SPAST gene / MLPA)
    • IMEGEN - Instituto de Medicina Genómica
    • More information
    • ITALY
    • LAZIO
    • ROMA
    • Molecular diagnosis of spastic paraplegia (SPAST, ATL1, SPG11, SPG15 genes)
    • IRCCS Ospedale Pediatrico Bambino Gesù
    • More information
    • GERMANY
    • Sachsen
    • DRESDEN
    • Molecular diagnosis of familial spastic paraplegia type 3, 4, 5A, 7, 8, 10, 11, 15, 17, 20 and 31 (ATL1, BSCL2, CYP7B1, KIAA0196, KIF5A, REEP1, SPAST, SPG7, SPG11, SPG20, ZFYVE26 genes: sequencing)
    • Gemeinschaftspraxis für Humangenetik
    • More information
    • SPAIN
    • La Rioja
    • LOGROÑO
    • Molecular diagnosis of autosomal dominant spastic paraplegia types 3, 4, 6 and 8, and recessive types 7 and 11 (ATL1, SPAST, NIPA1, KIAA0196, SPG7, SPG11 genes)
    • CIBIR - Centro de Investigación Biomédica de La Rioja
    • More information
    • ITALY
    • LOMBARDIA
    • MILANO
    • Molecular diagnosis of familial spastic paraplegia (SPAST, ATL1, SPG7, REEP1, BSCL2, CYP7B1 genes)
    • Fondazione IRCCS Istituto Neurologico "Carlo Besta"
    • More information
    • ITALY
    • SICILIA
    • TROINA
    • Molecular diagnosis of autosomal dominant spastic paraplegia (SPG4, SPG3, SPG10 genes)
    • IRCCS OASI Maria Santissima
    • More information
    • GERMANY
    • Mecklenburg-Vorpommern
    • ROSTOCK
    • Molecular diagnosis of familial spastic paraplegia (SPG1, SPG2, SPG3A, SPG4, SPG7, SPG13 and SPG20 genes)
    • Universitätsmedizin Rostock
    • More information
    • ITALY
    • EMILIA ROMAGNA
    • BOLOGNA
    • Molecular diagnosis of familial spastic paraplegia (SPAST gene)
    • Azienda Ospedaliera di Bologna - Policlinico S. Orsola-Malpighi
    • More information
    • ITALY
    • CALABRIA
    • MANGONE
    • Molecular diagnosis of familial spastic paraplegia (SPAST, ATL1, SPG7 genes)
    • CNR
    • More information
    • ITALY
    • VENETO
    • PADOVA
    • Molecular diagnosis of autosomal dominant spastic paraplegia type 4 (SPAST gene)
    • Università degli Studi di Padova
    • More information
    • ITALY
    • LOMBARDIA
    • BOSISIO PARINI
    • Molecular diagnosis of familial spastic paraplegia (SPG4, SPG6, SPG7, SPG 13, SPG17 genes)
    • IRCCS "E. Medea"
    • More information
    • SPAIN
    • Comunidad Valenciana
    • VALENCIA
    • Molecular diagnosis of autosomal dominant spastic paraplegia type 4. Gene SPAST
    • Progerie Molecular, S.L.
    • More information
    • SPAIN
    • Comunidad Valenciana
    • VALENCIA
    • Molecular diagnosis of autosomal dominant spastic paraplegia, types 3 and 4 (ATL1 and SPAST genes)
    • INCLIVA
    • More information
    • GERMANY
    • Baden-Württemberg
    • TÜBINGEN
    • Molecular diagnosis of familial spastic paraplegia SPG3, SPG4, SPG5, SPG7, SPG11, SPG15 and SPG31 (ATL1, BSCL2, CYP7B1, REEP1, SPAST, SPG7, SPG11, ZFYVE26 genes)
    • Universitätsklinikum Tübingen
    • More information
    • SPAIN
    • Cataluña
    • BADALONA
    • Molecular diagnosis of autosomal dominant spastic paraplegia type 4 (SPAST gene)
    • Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol
    • More information
    • SPAIN
    • Madrid
    • SAN SEBASTIÁN DE LOS REYES
    • Molecular diagnosis of autosomal dominant pure spastic paraplegia (entire coding sequence of SPAST, ATL1 , REEP1, KIF5A, NIPA1, KIAA0196 and HSPD1 genes / deletions in SPAST and ATL1 genes by MLPA analysis)
    • Laboratorio de Genética Clínica, S.L.
    • More information
    • SPAIN
    • Andalucía
    • CAMPANILLAS
    • Molecular diagnosis of autosomal dominant spastic paraplegia type 4 (SPAST gene / gene sequencing and MLPA)
    • GenoClinics
    • More information